CPS TECHNOLOGIES CORP/DE/ — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that CPS TECHNOLOGIES CORP/DE/ filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 30, 2017 | $14.58M | Mar 12, 2018 |
| FY2017 | Dec 31, 2016 | $15.35M | Mar 12, 2018 |
| FY2017 | Dec 26, 2015 | $21.76M | Mar 12, 2018 |
| FY2016 | Dec 27, 2014 | $23.14M | Mar 8, 2017 |
| FY2015 | Dec 28, 2013 | $21.41M | Mar 9, 2016 |
| FY2014 | Dec 29, 2012 | $14.05M | Mar 24, 2015 |
| FY2013 | Dec 31, 2011 | $19.81M | Mar 17, 2014 |
| FY2012 | Dec 25, 2010 | $21.40M | Mar 27, 2013 |
| FY2011 | Dec 26, 2009 | $12.98M | Mar 30, 2012 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $32.60M | Mar 3, 2026 |
| FY2025 | Dec 28, 2024 | $21.12M | Mar 3, 2026 |
| FY2024 | Dec 30, 2023 | $27.55M | Mar 17, 2025 |
| FY2023 | Dec 31, 2022 | $26.59M | Aug 2, 2024 |
| FY2022 | Dec 25, 2021 | $22.45M | Mar 16, 2023 |
| FY2021 | Dec 26, 2020 | $20.87M | Mar 10, 2022 |
| FY2020 | Dec 28, 2019 | $21.47M | Mar 17, 2021 |
| FY2019 | Dec 29, 2018 | $21.58M | Mar 13, 2020 |
| FY2018 | Dec 30, 2017 | $14.58M | Mar 15, 2019 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $5.29M | Mar 3, 2026 |
| FY2025 | Dec 28, 2024 | ($118.6K) | Mar 3, 2026 |
| FY2024 | Dec 30, 2023 | $6.83M | Mar 17, 2025 |
| FY2023 | Dec 31, 2022 | $7.30M | Aug 2, 2024 |
| FY2022 | Dec 25, 2021 | $4.79M | Mar 16, 2023 |
| FY2021 | Dec 26, 2020 | $4.17M | Mar 10, 2022 |
| FY2020 | Dec 28, 2019 | $2.54M | Mar 17, 2021 |
| FY2019 | Dec 29, 2018 | $2.91M | Mar 13, 2020 |
| FY2018 | Dec 30, 2017 | $1.66M | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | $2.16M | Mar 12, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $420.4K | Mar 3, 2026 |
| FY2025 | Dec 28, 2024 | ($3.14M) | Mar 3, 2026 |
| FY2024 | Dec 30, 2023 | $1.37M | Mar 17, 2025 |
| FY2023 | Dec 31, 2022 | $2.13M | Aug 2, 2024 |
| FY2022 | Dec 25, 2021 | $3.22M | Mar 16, 2023 |
| FY2021 | Dec 26, 2020 | $908.1K | Mar 10, 2022 |
| FY2020 | Dec 28, 2019 | ($638.2K) | Mar 17, 2021 |
| FY2019 | Dec 29, 2018 | ($3.71M) | Mar 13, 2020 |
| FY2019 | Dec 30, 2017 | ($1.72M) | Mar 13, 2020 |
| FY2017 | Dec 31, 2016 | ($453.6K) | Mar 12, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $444.0K | Mar 3, 2026 |
| FY2025 | Dec 28, 2024 | ($4.38M) | Mar 3, 2026 |
| FY2024 | Dec 30, 2023 | $1.70M | Mar 17, 2025 |
| FY2023 | Dec 31, 2022 | $2.23M | Aug 2, 2024 |
| FY2022 | Dec 25, 2021 | $513.0K | Mar 16, 2023 |
| FY2021 | Dec 26, 2020 | $914.2K | Mar 10, 2022 |
| FY2020 | Dec 28, 2019 | ($597.2K) | Mar 17, 2021 |
| FY2019 | Dec 29, 2018 | ($900.6K) | Mar 13, 2020 |
| FY2018 | Dec 30, 2017 | ($1.95M) | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | ($1.18M) | Mar 12, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $867.7K | Mar 3, 2026 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $4.85M | Mar 3, 2026 |
| FY2025 | Dec 28, 2024 | $4.26M | Mar 3, 2026 |
| FY2024 | Dec 30, 2023 | $5.13M | Mar 17, 2025 |
| FY2023 | Dec 31, 2022 | $5.07M | Aug 2, 2024 |
| FY2022 | Dec 25, 2021 | $4.28M | Mar 16, 2023 |
| FY2021 | Dec 26, 2020 | $3.26M | Mar 10, 2022 |
| FY2020 | Dec 28, 2019 | $3.14M | Mar 17, 2021 |
| FY2019 | Dec 29, 2018 | $3.81M | Mar 13, 2020 |
| FY2018 | Dec 30, 2017 | $3.61M | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | $3.34M | Mar 12, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $243.6K | Mar 3, 2026 |
| FY2025 | Dec 28, 2024 | ($3.48M) | Mar 3, 2026 |
| FY2024 | Dec 30, 2023 | $1.27M | Mar 17, 2025 |
| FY2023 | Dec 31, 2022 | $3.55M | Aug 2, 2024 |
| FY2022 | Dec 25, 2021 | $2.01M | Mar 16, 2023 |
| FY2021 | Dec 26, 2020 | $1.67M | Mar 10, 2022 |
| FY2020 | Dec 28, 2019 | ($1.26M) | Mar 17, 2021 |
| FY2019 | Dec 29, 2018 | ($373.6K) | Mar 13, 2020 |
| FY2018 | Dec 30, 2017 | ($1.79M) | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | $596.3K | Mar 12, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $730.7K | Mar 3, 2026 |
| FY2025 | Dec 28, 2024 | $994.3K | Mar 3, 2026 |
| FY2024 | Dec 30, 2023 | $718.3K | Mar 17, 2025 |
| FY2023 | Dec 31, 2022 | $439.8K | Aug 2, 2024 |
| FY2022 | Dec 25, 2021 | $514.3K | Mar 16, 2023 |
| FY2021 | Dec 26, 2020 | $323.0K | Mar 10, 2022 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $29.51M | Mar 3, 2026 |
| FY2025 | Dec 28, 2024 | $18.88M | Mar 3, 2026 |
| FY2024 | Dec 30, 2023 | $21.60M | Mar 17, 2025 |
| FY2023 | Dec 31, 2022 | $21.68M | Aug 2, 2024 |
| FY2022 | Dec 25, 2021 | $18.80M | Mar 16, 2023 |
| FY2021 | Dec 26, 2020 | $8.32M | Mar 10, 2022 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $4.88M | Mar 3, 2026 |
| FY2025 | Dec 28, 2024 | $4.36M | Mar 3, 2026 |
| FY2023 | Dec 31, 2023 | $4.28M | Mar 14, 2024 |
| FY2024 | Dec 30, 2023 | $4.28M | Mar 17, 2025 |
| FY2023 | Dec 31, 2022 | $5.97M | Aug 2, 2024 |
| FY2022 | Dec 25, 2021 | $5.63M | Mar 16, 2023 |
| FY2021 | Dec 26, 2020 | $1.96M | Mar 10, 2022 |
| FY2020 | Dec 28, 2019 | $3.69M | Mar 17, 2021 |
| FY2019 | Dec 29, 2018 | $2.66M | Mar 13, 2020 |
| FY2013 | Dec 28, 2013 | $2.28M | Mar 17, 2014 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $24.64M | Mar 3, 2026 |
| FY2025 | Dec 28, 2024 | $14.51M | Mar 3, 2026 |
| FY2023 | Dec 31, 2023 | $17.32M | Mar 14, 2024 |
| FY2025 | Dec 30, 2023 | $17.32M | Mar 3, 2026 |
| FY2023 | Dec 31, 2022 | $15.71M | Aug 2, 2024 |
| FY2023 | Dec 25, 2021 | $13.17M | Aug 2, 2024 |
| FY2022 | Dec 26, 2020 | $6.36M | Mar 16, 2023 |
| FY2021 | Dec 28, 2019 | $5.33M | Mar 10, 2022 |
| FY2019 | Dec 29, 2018 | $5.84M | Mar 13, 2020 |
| FY2018 | Dec 30, 2017 | $9.32M | Mar 15, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | ($25.47M) | Mar 3, 2026 |
| FY2025 | Dec 28, 2024 | ($25.89M) | Mar 3, 2026 |
| FY2023 | Dec 31, 2023 | ($22.75M) | Mar 14, 2024 |
| FY2024 | Dec 30, 2023 | ($22.75M) | Mar 17, 2025 |
| FY2023 | Dec 31, 2022 | ($24.13M) | Aug 2, 2024 |
| FY2022 | Dec 25, 2021 | ($26.26M) | Mar 16, 2023 |
| FY2021 | Dec 26, 2020 | ($29.47M) | Mar 10, 2022 |
| FY2020 | Dec 28, 2019 | ($30.38M) | Mar 17, 2021 |
| FY2019 | Dec 29, 2018 | ($29.74M) | Mar 13, 2020 |
| FY2018 | Dec 30, 2017 | ($26.04M) | Mar 15, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $4.47M | Mar 3, 2026 |
| FY2025 | Dec 28, 2024 | $3.28M | Mar 3, 2026 |
| FY2024 | Dec 30, 2023 | $8.81M | Mar 17, 2025 |
| FY2023 | Dec 31, 2022 | $8.27M | Aug 2, 2024 |
| FY2022 | Dec 25, 2021 | $5.05M | Mar 16, 2023 |
| FY2021 | Dec 26, 2020 | $195.2K | Mar 10, 2022 |
| FY2020 | Dec 28, 2019 | $134.0K | Mar 17, 2021 |
| FY2020 | Dec 29, 2018 | $628.8K | Mar 17, 2021 |
| FY2019 | Dec 30, 2017 | $1.34M | Mar 13, 2020 |
| FY2018 | Dec 31, 2016 | $3.41M | Mar 15, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 28, 2024 | $8.1K | Mar 17, 2025 |
| FY2023 | Dec 30, 2023 | $54.9K | Aug 2, 2024 |
| FY2022 | Dec 31, 2022 | $98.7K | Mar 16, 2023 |
| FY2021 | Dec 31, 2021 | $154.6K | Mar 10, 2022 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | 0 | Mar 3, 2026 |
| FY2025 | Dec 28, 2024 | 0 | Mar 3, 2026 |
| FY2024 | Dec 30, 2023 | 0 | Mar 17, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Aug 2, 2024 |
| FY2022 | Dec 25, 2021 | 0 | Mar 16, 2023 |
| FY2021 | Dec 26, 2020 | 0 | Mar 10, 2022 |
| FY2020 | Dec 28, 2019 | 0 | Mar 17, 2021 |
| FY2019 | Dec 29, 2018 | 0 | Mar 13, 2020 |
| FY2018 | Dec 30, 2017 | 0 | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | 0 | Mar 12, 2018 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | 0 | Mar 3, 2026 |
| FY2025 | Dec 28, 2024 | 0 | Mar 3, 2026 |
| FY2024 | Dec 30, 2023 | 0 | Mar 17, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Aug 2, 2024 |
| FY2022 | Dec 25, 2021 | 0 | Mar 16, 2023 |
| FY2021 | Dec 26, 2020 | 0 | Mar 10, 2022 |
| FY2020 | Dec 28, 2019 | 0 | Mar 17, 2021 |
| FY2019 | Dec 29, 2018 | 0 | Mar 13, 2020 |
| FY2018 | Dec 30, 2017 | 0 | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | 0 | Mar 12, 2018 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | 17.99M | Mar 3, 2026 |
| FY2025 | Dec 28, 2024 | 14.53M | Mar 3, 2026 |
| FY2023 | Dec 31, 2023 | 14.52M | Mar 14, 2024 |
| FY2024 | Dec 30, 2023 | 14.52M | Mar 17, 2025 |
| FY2023 | Dec 31, 2022 | 14.45M | Aug 2, 2024 |
| FY2022 | Dec 25, 2021 | 14.35M | Mar 16, 2023 |
| FY2021 | Dec 26, 2020 | 13.31M | Mar 10, 2022 |
| FY2020 | Dec 28, 2019 | 13.21M | Mar 17, 2021 |
| FY2019 | Dec 29, 2018 | 13.21M | Mar 13, 2020 |
| FY2018 | Dec 30, 2017 | 13.20M | Mar 15, 2019 |